Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma.
about
Pharmacokinetics and drug interactions of eslicarbazepine acetate.Simultaneous UPLC-MS/MS determination of antiepileptic agents for dose adjustment.Development and validation of a reversed-phase HPLC method for licarbazepine monitoring in serum of patients under oxcarbazepine treatment.A critical review of microextraction by packed sorbent as a sample preparation approach in drug bioanalysis.Development and Validation of an RP-HPLC Method for Quantitative Estimation of Eslicarbazepine Acetate in Bulk Drug and Tablets.[Therapeutic drug monitoring of three antiepileptic drugs - Back on twenty years of experience].An HPLC-DAD method for the simultaneous quantification of opicapone (BIA 9-1067) and its active metabolite in human plasma.Quantitative bioanalytical and analytical method development of dibenzazepine derivative, carbamazepine: A review.Identification, synthesis and characterization of an unknown process related impurity in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS, 1H, 13C and 1H-1H COSY NMR.Sensitive inexpensive HPLC determination of four antiepileptic drugs in human plasma: application to PK studies.Simultaneous extraction and quantification of lamotrigine, phenobarbital, and phenytoin in human plasma and urine samples using solidified floating organic drop microextraction and high-performance liquid chromatography.
P2860
Q34276263-3290C19F-53E9-4114-A341-DAFA2C3F1F88Q36225438-9362F118-B4A7-4588-9951-98722C30AB2AQ36275095-54E346BB-95F1-4636-A07C-395ED9F92A90Q38112479-FF70C08A-ADB5-4EA8-8135-1D7570019220Q41964930-8DD310C2-A1D9-449C-9234-77840936DD9BQ42327867-BA20CAB8-DDA9-4477-8CFB-ABF216496DF2Q43734498-0C2E4053-7779-444F-92B3-A9C682EE2B3BQ49215698-9766786A-1276-4B06-B4E1-A98E1DBD4182Q50196611-2CA7276E-AAC8-4904-B364-C15E2B32B4A1Q51792085-462A3B64-E4DB-4564-8110-D4797B29F120Q53513731-4EDE5803-8837-4D75-934F-4DB58E823DEB
P2860
Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Development and validation of ...... n metabolites in human plasma.
@en
Development and validation of ...... n metabolites in human plasma.
@nl
type
label
Development and validation of ...... n metabolites in human plasma.
@en
Development and validation of ...... n metabolites in human plasma.
@nl
prefLabel
Development and validation of ...... n metabolites in human plasma.
@en
Development and validation of ...... n metabolites in human plasma.
@nl
P50
P1476
Development and validation of ...... n metabolites in human plasma.
@en
P2093
Joana Sousa
P2888
P304
P356
10.1007/S00216-010-3673-0
P407
P577
2010-04-18T00:00:00Z